ATE449163T1 - Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung - Google Patents

Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung

Info

Publication number
ATE449163T1
ATE449163T1 AT01943584T AT01943584T ATE449163T1 AT E449163 T1 ATE449163 T1 AT E449163T1 AT 01943584 T AT01943584 T AT 01943584T AT 01943584 T AT01943584 T AT 01943584T AT E449163 T1 ATE449163 T1 AT E449163T1
Authority
AT
Austria
Prior art keywords
cell
cell populations
preparing
derived cell
culture
Prior art date
Application number
AT01943584T
Other languages
English (en)
Inventor
Jean-Thomas Vilquin
Jean-Pierre Marolleau
Jacques Tremblay
Isabelle Robert
Brigitte Ternaux
Original Assignee
Assist Publ Hopitaux De Paris
Inst Nat Sante Rech Med
Ass Fr Contre Les Myopathies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publ Hopitaux De Paris, Inst Nat Sante Rech Med, Ass Fr Contre Les Myopathies filed Critical Assist Publ Hopitaux De Paris
Application granted granted Critical
Publication of ATE449163T1 publication Critical patent/ATE449163T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Adornments (AREA)
AT01943584T 2000-06-07 2001-06-07 Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung ATE449163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007304A FR2810045B1 (fr) 2000-06-07 2000-06-07 Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
PCT/FR2001/001768 WO2001094555A1 (fr) 2000-06-07 2001-06-07 Procede d'obtention de populations cellulaires caracterisees d'origine musculaire et utilisations

Publications (1)

Publication Number Publication Date
ATE449163T1 true ATE449163T1 (de) 2009-12-15

Family

ID=8851058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01943584T ATE449163T1 (de) 2000-06-07 2001-06-07 Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung

Country Status (14)

Country Link
US (3) US20040043008A1 (de)
EP (1) EP1292671B9 (de)
JP (1) JP2003535586A (de)
AT (1) ATE449163T1 (de)
AU (2) AU6612701A (de)
BR (1) BR0111497A (de)
CA (1) CA2411762A1 (de)
CY (1) CY1109745T1 (de)
DE (1) DE60140536D1 (de)
DK (1) DK1292671T3 (de)
ES (1) ES2335747T3 (de)
FR (1) FR2810045B1 (de)
PT (1) PT1292671E (de)
WO (1) WO2001094555A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5159901A (en) * 2000-04-14 2001-10-30 Univ Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
AU2003234181A1 (en) * 2002-05-10 2003-11-11 Isolagen Technologies, Inc. Treatments with autologous fibroblast
ATE482713T1 (de) * 2003-04-25 2010-10-15 Univ Pittsburgh Von muskeln stammende zellen (mdcs) zur förderung und verbesserung der nervenreparatur und - regeneration
US20070202592A1 (en) * 2004-07-08 2007-08-30 Yasuo Kitagawa Pluripotent Cells Distributed Ubiquitously In Animal Tissue, Which Proliferate Selectively In Lower-Serum Culture
FR2890977A1 (fr) * 2005-09-19 2007-03-23 Assist Publ Hopitaux De Paris Procede d'obtention de cellules musculaires lisses humaines et leurs applications
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
US20090155221A1 (en) * 2007-05-29 2009-06-18 Thomas Payne Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
EP2206774A1 (de) 2008-12-23 2010-07-14 Genzyme Corporation Von Muskeln stammende Zellen mit Differenzierungsfähigkeiten
SG176806A1 (en) * 2009-07-09 2012-01-30 Centocor Ortho Biotech Inc Cardiac tissue-derived cells
FR3074018B1 (fr) 2017-11-27 2020-09-11 Lab Francais Du Fractionnement Procede de cryoconservation de cellules a visee therapeutique
FR3088541B1 (fr) 2018-11-15 2021-11-05 Lab Francais Du Fractionnement Procede de conservation de cellules a visee therapeutique
CA3142248A1 (en) 2019-05-31 2020-12-03 Figene, Llc Fibroblast therapy for treatment of duchenne muscular dystrophy
WO2021065989A1 (ja) * 2019-09-30 2021-04-08 テルモ株式会社 Ｃｄ５６陽性細胞の比率を高めるための方法
KR102858797B1 (ko) * 2022-12-08 2025-09-12 주식회사 팡세 근육줄기세포의 분화능 예측을 위한 cd56의 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5538722A (en) * 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
US5574205A (en) * 1989-07-25 1996-11-12 Cell Genesys Homologous recombination for universal donor cells and chimeric mammalian hosts
DE69032112T2 (de) * 1989-08-03 1998-07-09 Univ California Verfahren zur Isolierung von fetalen Zytotrophoblastzellen
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5196315A (en) * 1990-05-01 1993-03-23 The Johns Hopkins University Human neuronal cell line
WO1994007138A1 (en) * 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
DE69430846T2 (de) * 1993-08-27 2003-01-16 Dana-Farber Cancer Institute, Boston Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
EP1064356A2 (de) * 1998-03-23 2001-01-03 ZymoGenetics, Inc. Herz-derivierte stammzellen
DE69939956D1 (de) * 1998-05-01 2009-01-02 Univ Pittsburgh Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz
US7368420B1 (en) * 1998-10-02 2008-05-06 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Akt compositions for enhancing survival of cells
US20030113301A1 (en) * 1999-07-23 2003-06-19 Albert Edge Muscle cells and their use in cardiac repair
AU770889B2 (en) * 1999-07-23 2004-03-04 Genvec, Inc. Muscle cells and their use in cardiac repair
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations

Also Published As

Publication number Publication date
CY1109745T1 (el) 2014-09-10
EP1292671B9 (de) 2010-05-19
WO2001094555A1 (fr) 2001-12-13
EP1292671B1 (de) 2009-11-18
US20110014159A1 (en) 2011-01-20
US20060088508A1 (en) 2006-04-27
AU6612701A (en) 2001-12-17
EP1292671A1 (de) 2003-03-19
FR2810045A1 (fr) 2001-12-14
ES2335747T3 (es) 2010-04-05
CA2411762A1 (fr) 2001-12-13
DK1292671T3 (da) 2010-03-15
BR0111497A (pt) 2004-04-06
US20040043008A1 (en) 2004-03-04
FR2810045B1 (fr) 2004-09-03
PT1292671E (pt) 2010-02-05
JP2003535586A (ja) 2003-12-02
DE60140536D1 (de) 2009-12-31
AU2001266127B2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
DE60140536D1 (de) Verfahren zur gewinnung von muskelnabstammenden zellpopulationen und deren verwendung
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
US5851831A (en) Method for long term subculture of dermal papilla cells
Nebe et al. Interface interactions of osteoblasts with structured titanium and the correlation between physicochemical characteristics and cell biological parameters
Kuznetsov et al. In vivo bone formation by progeny of human embryonic stem cells
EP1035215A3 (de) Verfahren und Sondenset zur Erkennung von Krebs
AR000921A1 (es) Composicion como medio de cultivo para soportar el crecimiento de poblaciones celulares. metodo in vitro para sostener el crecimiento in vitro dede celulas eucarioticas, respectivamente para in vitro incrementar las propiedades del tejido submucoso para cultivar celulas islote o analizar in
DE50011820D1 (de) Verfahren zur kultivierung von krebszellen aus humangewebe und vorrichtung zur aufbereitung von gewebeproben
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
ATE488244T1 (de) Transplantate für myokardiale narben, methoden and zelluläre präparationen dafür
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
DE69935999D1 (de) Methoden zur introduktion heterologer zellen in fische
DE69714775D1 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
EP1499710A4 (de) Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
Silvério et al. Stem cells: potential therapeutics for periodontal regeneration
ATE392469T1 (de) Verfahren zur ex vivo bildung von säugetier- knochen und dessen verwendungen
EP1270719A3 (de) Hemangioblasten enthaltender Zellverband und dessen Herstellungsverfahren
FR2848565B1 (fr) Lignee de cellules dendritiques gen2.2
DE69913533D1 (de) Reagentien für cyp2d fluoreszenztest
AU7345500A (en) Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate
Clausen et al. Characterization of human bone cells derived from the maxillary alveolar ridge
JP2020063192A (ja) 真皮線維芽細胞の培養上清液を含む化粧用組成物およびその製造方法
IL165250A (en) Methods of isolating cd 34 negative precursor endothelial cells from a biological sample
EP4234024A3 (de) Verfahren und zusammensetzungen zur herstellung von retinapigmentpithelzellen
Drukała et al. Comparison of proliferation and motile activity between human keratinocytes isolated from skin and oral mucosa

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292671

Country of ref document: EP